Overdosing GLP-1 agonists like semaglutide can cause a lot of GI issues, which are severe and prolonged
An Honest Look at the Evidence IV therapy is popular, and it is also heavily over-marketed, so it is worth being straight about what the evidence does and does not show
Once you puncture the vial's stopper, you've introduced a potential entry point for airborne bacteria
The synergy between receptor pathways produces outcomes that none could achieve individually
The Bridge only covers GLP-1s prescribed for weight management
Rodent studies suggest BPC-157 may enhance healing of muscle, tendon, ligament, and nerve injuries while also reducing inflammation, but clinical evidence in humans remains limited to small, uncontrolled observations